Intuitive SurgicalISRGEarnings & Financial Report
Nasdaq · Health Care · Health Care Equipment
Intuitive Surgical, Inc. is an American biotechnology company that develops, manufactures, and markets robotic products designed to improve clinical outcomes of patients through minimally invasive surgery, most notably with the da Vinci Surgical System. The company is part of the Nasdaq-100, S&P 100 and S&P 500. As of 31 December 2021, Intuitive Surgical had an installed base of 6,730 da Vinci Surgical Systems, including 4,139 in the U.S.
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| The Vanguard Group | 8.63% | 30.4M | — | 2024-02-13 |
| BlackRock, Inc. | 8.40% | 29.6M | — | 2024-01-25 |
| T. ROWE PRICE ASSOCIATES, INC. | 4.80% | 17.0M | — | 2024-02-14 |
Insider Transactions
Net 90d: −$6.62M · buys $0 / sells $6.62MRange:
Action:
Role:
| Insider | Role | Action | ||||
|---|---|---|---|---|---|---|
| 2026-04-29 | Ladd Amy L | Director | Sell (open market) | 119 | $463.50 | $55.2K |
| 2026-04-28 | Ladd Amy L | Director | Sell (open market) | 500 | $473.46 | $236.7K |
| 2026-03-10 | Myriam Curet | EVP & Chief Medical Officer | Option exercise | 105 | $229.39 | $24.1K |
| 2026-03-10 | Myriam Curet | EVP & Chief Medical Officer | Sell (open market) | 105 | $493.95 | $51.9K |
| 2026-03-09 | Mark Brosius | SVP & Chief Mfg and Supply Cha | Sell (open market) | 645 | $485.01 | $312.8K |
| 2026-03-06 | Mark Brosius | SVP & Chief Mfg and Supply Cha | Sell (open market) | 648 | $490.19 | $317.6K |
| 2026-03-05 | Mark Brosius | SVP & Chief Mfg and Supply Cha | Sell (open market) | 648 | $495.20 | $320.9K |
| 2026-03-04 | Mark Brosius | SVP & Chief Mfg and Supply Cha | Sell (open market) | 2.4K | $498.68 | $1.18M |
| 2026-03-03 | Mark Brosius | SVP & Chief Mfg and Supply Cha | Sell (open market) | 648 | $488.10 | $316.3K |
| 2026-03-03 | Myriam Curet | EVP & Chief Medical Officer | Sell (open market) | 4.7K | $487.18 | $2.30M |
1–10 of 52
Page 1 / 6